Condition: Sessile Colonic Polyp · Serrated Lesion · Sessile Serrated Lesion · Sponsor: Evergreen General Hospital, Taiwan
The goal of this clinical trial is to compare the detection rate of clinically significant serrated lesions (CSSL) in participants undergoing water exchange (WE) colonoscopy with artificial intelligence (AI)-based computer-aided detection (CADe) for screening, surveillance, diagnosis for symptoms, or referred owing to a positive fecal immunochemical test (FIT) or guaiac fecal occult blood test (gFOBT) result. There will be two arms in this study: WE with AI-assisted CADe (WEAID) control and WEAID plus linked-color imaging (LCI). The main question it aims to answer is whether the addition of LCI into WEAID colonoscopy increases CSSL detection rate. Both groups use water instead of air to insert the colonoscope into the cecum. The control method uses CADe to help detect colonic lesions. The study method uses a combination of CADe and LCI to detect lesions. Researchers will compare CSSL detection rate to see if the addition of LCI increases the detection of CSSL during CADe-assisted WE colonoscopy.
This description comes directly from the study's public registry record.
Chi-Liang Cheng, MD · +886 919 768058 · chiliang.cheng@gmail.com
Rungsun Rerknimitr, MD · +66 81 902 6633 · ERCP@live.com
Always discuss trial participation with your own doctor first.
| University of Montreal Medical Center (CHUM) | Montreal, Quebec, Canada | Not Yet Recruiting |
| Ospedale Valduce | Como, Italy | Not Yet Recruiting |
| Evergreen General Hospital | Taoyuan, Taiwan | Recruiting |
| King Chulalongkorn Memorial Hospital | Bangkok, Thailand | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07127471